NCT04756232View on ClinicalTrials.gov

Cholinergic Mechanisms of Attention in Aging

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

May 1, 2025

Conditions

Subjective Cognitive Decline

Interventions

DRUG

Mecamylamine Challenge

Mecamylamine 20 mg oral pill administered once

OTHER

Placebo Comparator Challenge

Matching placebo oral pill administered once

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER